China SXT Pharmaceuticals (SXTC) Total Liabilities (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Total Liabilities of $5.0 million for Q1 2026, down 18.9% year-over-year from $6.2 million in Q1 2025, and down 17.53% quarter-over-quarter from $6.1 million in Q3 2025.
China SXT Pharmaceuticals (SXTC) Total Liabilities (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Total Liabilities history runs 9 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 18.9% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (down 18.9% YoY), while the FY2026 annual figure was $5.0 million, down 18.9% from the prior year.
- Total Liabilities for Q1 2026 stood at $5.0 million, down from $6.1 million in the prior quarter.
- The five-year high for Total Liabilities was $17.1 million in Q1 2022, with the low at $5.0 million in Q1 2026.
- The 5-year median for Total Liabilities is $9.2 million (2024), against an average of $10.1 million.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities jumped 67.82% in 2024, then slumped 61.66% in 2025.
- China SXT Pharmaceuticals' Total Liabilities stood at $7.3 million in 2022, then surged by 30.44% to $9.5 million in 2023, then surged by 67.82% to $16.0 million in 2024, then plunged by 61.66% to $6.1 million in 2025, then decreased by 17.53% to $5.0 million in 2026.
- Business Quant data shows SXTC's Total Liabilities at $5.0 million in Q1 2026, $6.1 million in Q3 2025, and $6.2 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 2.12 Bn |
| 10 | China SXT Pharmaceuticals | 32,922.00 | -28.14 Mn | - | 5.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.05 Mn |
| Sep 30, 2025 | 6.12 Mn |
| Mar 31, 2025 | 6.22 Mn |
| Sep 30, 2024 | 15.96 Mn |
| Mar 31, 2024 | 9.20 Mn |
| Sep 30, 2023 | 9.51 Mn |
| Mar 31, 2023 | 14.86 Mn |
| Sep 30, 2022 | 7.29 Mn |
| Mar 31, 2022 | 17.12 Mn |
| Sep 30, 2021 | 8.88 Mn |
| Mar 31, 2021 | 18.59 Mn |
| Sep 30, 2020 | 5.52 Mn |
| Mar 31, 2020 | 12.30 Mn |
| Sep 30, 2019 | 11.64 Mn |
| Mar 31, 2019 | 6.36 Mn |
| Sep 30, 2018 | 7.95 Mn |
| Mar 31, 2018 | 4.37 Mn |